Support for trauma exposure victims

Early Support After Exposure to Trauma

Not applicable Interventional Norwegian Center for Violence and Traumatic Stress Studies · NCT06592677

This study tests a new online therapy for people dealing with post-traumatic stress symptoms after a traumatic event to see if it helps them feel better and is cost-effective.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment360 (estimated)
Ages16 Years to 99 Years
SexAll
SponsorNorwegian Center for Violence and Traumatic Stress Studies Academic / other
Locations29 sites (Asker, Asker and 28 other locations)
Trial IDNCT06592677 on ClinicalTrials.gov

What this trial studies

This study evaluates the effectiveness and cost-effectiveness of a condensed internet-delivered prolonged exposure therapy (CIPE) for individuals experiencing post-traumatic stress symptoms (PTSS) after a traumatic event. Participants will receive CIPE approximately one month after trauma, alongside treatment-as-usual (TAU) from municipal crisis teams. The intervention is designed to be therapist-assisted and is based on established principles of prolonged exposure therapy. The study aims to fill the gap in evidence-based preventive interventions available for trauma victims in Norway.

Who should consider this trial

Good fit: Ideal candidates are individuals aged 16 and above who have experienced a traumatic event within the last month and are receiving support from a municipal crisis team.

Not a fit: Patients with severe psychopathology requiring specialized care or ongoing trauma may not benefit from this intervention.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce the incidence of PTSD among trauma victims by providing timely and effective support.

How similar studies have performed: Previous studies have shown that internet-delivered prolonged exposure therapy is feasible and effective, suggesting potential success for this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Receives support from a municipal crisis team
* Exposure to a traumatic event (as defined by criteria A for the diagnosis of post-traumatic stress disorder (PTSD) in the DSM-5) within the last seven weeks before randomization
* A total score of 10 or above on the PTSD Symptom Checklist-5 at the time of randomization
* Age 16 or above
* Written informed consent
* Writes and speaks English and/or Norwegian

Exclusion Criteria:

* Severe psychopathology in need of specialized health care (e.g., psychotic symptoms, or high suicide risk) or substance dependence syndrome in need of specialized health care
* Known or evident severe cognitive impairment
* Ongoing traumatization, violence, or threats
* Unstable dose of psychotropic medication two weeks prior to randomization
* Concurrent therapy elsewhere before randomization

Where this trial is running

Asker, Asker and 28 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Post-traumatic Stress DisorderCIPEPTSDIndicated preventionProlonged Exposure
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.